Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Holst JJ, Rosenkilde MM
The aim of this retrospective study is to report and analyze the results of the use of arGLP-1 in patients experiencing insufficient weight loss or weight regain after bariatric surgery
The real problem is that we simply dont know what effects melanotan II usage could have and because this is being distributed illegally, it is not regulated and monitored by the usual stringent medical regulations, as Dr Wedgeworth says
A 3-year follow-up survey of 1,200 recipients in Manhattan, New York shows that even if overall weight rebounded by 3.0 to 5.0 kg, the circumference increase in original injection sites like the outer thighs was only 0.2 to 0.5 cm
Research reported in JAMA in December 2023 also emphasized that patients may need to stay on the medications long term in order to keep the weight off
Shapsis focuses on evidence-based care, medication safety, and realistic long-term outcomes
